InMed Pharmaceuticals Inc.
INM
$1.34
$0.021.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.61% | 68.10% | -38.24% | -63.88% | -17.03% |
| Total Receivables | 20.65% | 31.83% | 77.08% | -29.58% | 71.61% |
| Inventory | -26.99% | -22.75% | -31.83% | 48.15% | 7.68% |
| Prepaid Expenses | 28.81% | -32.66% | -50.14% | -42.14% | -30.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 48.35% | 48.08% | -36.31% | -53.68% | -12.24% |
|
|
|||||
| Total Current Assets | 48.35% | 48.08% | -36.31% | -53.68% | -12.24% |
| Net Property, Plant & Equipment | -34.36% | -20.62% | -19.13% | -16.89% | 118.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.33% | -9.12% | -8.92% | -8.75% | -8.56% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -1.77% |
| Total Assets | 27.67% | 31.78% | -30.53% | -44.27% | -4.14% |
|
|
|||||
| Total Accounts Payable | -17.80% | -40.90% | 39.05% | 87.47% | 18.19% |
| Total Accrued Expenses | 5.65% | 4.72% | 16.56% | -10.80% | -15.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.12% | 37.04% | 24.23% | 15.24% | 44.81% |
| Total Finance Division Other Current Liabilities | 8,340.00% | -98.29% | -93.22% | -90.57% | -- |
| Total Other Current Liabilities | 8,340.00% | -98.29% | -93.22% | -90.57% | -- |
| Total Current Liabilities | 8.29% | -6.69% | 20.29% | 6.57% | 7.22% |
|
|
|||||
| Total Current Liabilities | 8.29% | -6.69% | 20.29% | 6.57% | 7.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -66.00% | -52.58% | -42.18% | -34.08% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -14.46% | -18.01% | 0.19% | -6.57% | 54.55% |
|
|
|||||
| Common Stock & APIC | 9.58% | 10.49% | 3.58% | 1.12% | 4.97% |
| Retained Earnings | -7.41% | -7.48% | -7.76% | -7.51% | -6.56% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 38.06% | 45.93% | -36.77% | -51.60% | -12.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.06% | 45.93% | -36.77% | -51.60% | -12.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 38.06% | 45.93% | -36.77% | -51.60% | -12.35% |
|
|
|||||